Likewise, Maniam et al. demonstrated that combined chemotherapeutic treatments enhanced Bax expression while reducing Bcl-2 in pancreatic tumor models, thereby shifting the Bax/Bcl-2 ratio toward apoptosis [27]. The gene discussed is BAX; the disease is pancreatic neoplasm.